J. Goldman & Co’s PolyPid PYPD Stock Holding History
Bought
Maintained
Sold
Other funds holding PYPD
ACM
RA
DCM
ACM
SPM
QC
J. Goldman & Co's PYPD Position: Q2 2026 in Review
J. Goldman & Co reduced its PolyPid (PYPD) stake by 34% in Q2 2026, selling an estimated $232K and leaving 99,183 shares worth $504K. The position accounts for 0.01% of the portfolio, ranked #554.
J. Goldman & Co first reported a position in PYPD in Q4 2024 and has held it in 7 quarters since. The position peaked at $748K in Q4 2025. 33 funds tracked by Wall St. Rank hold PYPD as of Q2 2026.
- J. Goldman & Co held 99,183 shares of PolyPid worth $504K as of Q2 2026.
- J. Goldman & Co sold 50,316 PolyPid shares in Q2 2026, an estimated $232K.
- PolyPid made up 0.01% of J. Goldman & Co's portfolio in Q2 2026, its #554 holding.
- J. Goldman & Co first reported a position in PolyPid in Q4 2024 and has held it in 7 quarters since.
- J. Goldman & Co's PolyPid position peaked at $748K in Q4 2025.
- 33 funds tracked by Wall St. Rank held PolyPid as of Q2 2026.
Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.